{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:10:21Z","timestamp":1768558221145,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK107871"],"award-info":[{"award-number":["K23DK107871"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpagonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric and Adolescent Gynecology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jpag.2020.08.017","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T04:45:17Z","timestamp":1599626717000},"page":"33-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Twelve-month Continuation of the Etonogestrel Implant in Adolescents With Polycystic Ovary Syndrome"],"prefix":"10.1016","volume":"34","author":[{"given":"Eliza","family":"Buyers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy E.","family":"Sass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron D.","family":"Severn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Pyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Cree-Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpag.2020.08.017_bib1","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadzki","year":"1992"},{"key":"10.1016\/j.jpag.2020.08.017_bib3","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.steroids.2013.04.004","article-title":"Cancer risk and PCOS","volume":"78","author":"Dumesic","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.jpag.2020.08.017_bib4","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(03)13409-5","article-title":"Polycystic ovary syndrome and endometrial carcinoma","volume":"361","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jpag.2020.08.017_bib5","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2020.08.017_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/OAJC.S85543","article-title":"Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits","volume":"8","author":"deMelo","year":"2017","journal-title":"Open Access J Contracept"},{"key":"10.1016\/j.jpag.2020.08.017_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2020.08.017_bib8","series-title":"Merck & Co, Inc. Nexplanon\u00ae (etonogestrel implant). University of Colorado Anschutz","year":"2016"},{"key":"10.1016\/j.jpag.2020.08.017_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00001703-200106000-00015","article-title":"Endometrial effects of etonogestrel (Implanon) contraceptive implant","volume":"13","author":"Varma","year":"2001","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.jpag.2020.08.017_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.contraception.2011.03.001","article-title":"Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project","volume":"84","author":"Mestad","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2020.08.017_bib11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jadohealth.2015.10.254","article-title":"Etonogestrel implants in adolescents: experience, satisfaction, and continuation","volume":"58","author":"Obijuru","year":"2016","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jpag.2020.08.017_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.contraception.2016.02.030","article-title":"Twelve-month discontinuation of etonogestrel implant in an outpatient pediatric setting","volume":"94","author":"Berlan","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2020.08.017_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Informatics"},{"key":"10.1016\/j.jpag.2020.08.017_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/AOG.0b013e31821188ad","article-title":"Continuation and satisfaction of reversible contraception","volume":"117","author":"Peipert","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2020.08.017_bib15","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/AOG.0000000000003072","article-title":"ACOG practice bulletin no. 206: use of hormonal contraception in women with coexisting medical conditions","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2020.08.017_bib16","series-title":"The Affordable Care ACT\u2019s birth control benefit: progress on implementation and continuing challenges","year":"2016"},{"issue":"6 Suppl 1","key":"10.1016\/j.jpag.2020.08.017_bib17","first-page":"S1","article-title":"Progestin-only oral contraception: a comprehensive review","volume":"50","author":"McCann","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2020.08.017_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/AOG.0000000000003089","article-title":"Side effects and health benefits of depot medroxyprogesterone acetate: a systematic review","volume":"133","author":"Dianat","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2020.08.017_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2020.08.017_bib20","author":"Bayer"},{"key":"10.1016\/j.jpag.2020.08.017_bib21","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jpag.2019.07.001","article-title":"Intrauterine devices: effective contraception with noncontraceptive benefits for adolescents","volume":"32","author":"Adeyemi-Fowode","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jpag.2020.08.017_bib22","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jpag.2019.04.007","article-title":"Hormonal contraceptives, intrauterine devices, gonadotropin-releasing hormone analogues and testosterone: menstrual suppression in special adolescent populations","volume":"32","author":"Pradhan","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jpag.2020.08.017_bib23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/AOG.0000000000001036","article-title":"Young age, nulliparity, and continuation of long-acting reversible contraceptive methods","volume":"126","author":"Abraham","year":"2015","journal-title":"Obstetr Gynecol"},{"key":"10.1016\/j.jpag.2020.08.017_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2337\/dc15-1206","article-title":"Pregnancy outcomes in youth with type 2 diabetes: the TODAY Study experience","volume":"39","author":"Klingensmith","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpag.2020.08.017_bib25","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/oby.20213","article-title":"Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women","volume":"21","author":"Teede","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jpag.2020.08.017_bib26","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.fertnstert.2008.02.140","article-title":"Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials","volume":"91","author":"Darney","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2020.08.017_bib27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"32","author":"Cooney","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2020.08.017_bib28","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/AOG.0000000000001644","article-title":"Long-Acting Reversible Contraceptive Expert Work G: Committee opinion no. 672: clinical challenges of long-acting reversible contraceptive methods","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2020.08.017_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/humrep\/deh048","article-title":"The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ): a validation","volume":"19","author":"Jones","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2020.08.017_bib30","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2018.01.038","article-title":"Androgen Excess-Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome","volume":"109","author":"Dokras","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2020.08.017_bib31","first-page":"37","article-title":"Oral spironolactone in post-teenage female patients with acne vulgaris: practical considerations for the clinician based on current data and clinical experience","volume":"5","author":"Kim","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jpag.2020.08.017_bib32","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2337\/dc12-2390","article-title":"Safety and tolerability of the treatment of youth-onset type 2 diabetes: the TODAY experience","volume":"36","author":"Group","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpag.2020.08.017_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/13625187.2016.1210122","article-title":"Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial","volume":"21","author":"Hou","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.jpag.2020.08.017_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.contraception.2018.02.009","article-title":"Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: a proof-of-concept trial","volume":"97","author":"Chen","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2020.08.017_bib35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/13625180802075315","article-title":"Effect of the subdermal contraceptive etonogestrel implant (Implanon) on biochemical and hormonal parameters (three years follow-up)","volume":"13","author":"Inal","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.jpag.2020.08.017_bib36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/13625180802382604","article-title":"Etonogestrel implant in women with diabetes mellitus","volume":"13","author":"Vicente","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.jpag.2020.08.017_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejogrb.2016.04.025","article-title":"Metabolic safety of the etonogestrel contraceptive implant in healthy women over a 3-year period","volume":"202","author":"Villas-Boas","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jpag.2020.08.017_bib38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.contraception.2010.01.014","article-title":"Effect of etonogestrel implant on serum lipids, liver function tests and hemoglobin levels","volume":"81","author":"Dilbaz","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2020.08.017_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/AOG.0b013e3181cb50b5","article-title":"ACOG practice bulletin no. 110: noncontraceptive uses of hormonal contraceptives","volume":"115","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2020.08.017_bib40","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1097\/AOG.0000000000002656","article-title":"ACOG practice bulletin no. 194: polycystic ovary syndrome","volume":"131","year":"2018","journal-title":"Obstet Gynecol"}],"container-title":["Journal of Pediatric and Adolescent Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318820303144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318820303144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:46:49Z","timestamp":1761054409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083318820303144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1083318820303144"],"URL":"https:\/\/doi.org\/10.1016\/j.jpag.2020.08.017","relation":{},"ISSN":["1083-3188"],"issn-type":[{"value":"1083-3188","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Twelve-month Continuation of the Etonogestrel Implant in Adolescents With Polycystic Ovary Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric and Adolescent Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpag.2020.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}